These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9678648)
1. A new approach to the light/dark test procedure in mice. Hascoët M; Bourin M Pharmacol Biochem Behav; 1998 Jul; 60(3):645-53. PubMed ID: 9678648 [TBL] [Abstract][Full Text] [Related]
2. A fully automated light/dark apparatus useful for comparing anxiolytic agents. Young R; Johnson DN Pharmacol Biochem Behav; 1991 Dec; 40(4):739-43. PubMed ID: 1687762 [TBL] [Abstract][Full Text] [Related]
3. Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test. Ago Y; Takahashi K; Nakamura S; Hashimoto H; Baba A; Matsuda T J Pharmacol Sci; 2007 Jun; 104(2):153-8. PubMed ID: 17538228 [TBL] [Abstract][Full Text] [Related]
4. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Shimada T; Matsumoto K; Osanai M; Matsuda H; Terasawa K; Watanabe H Gen Pharmacol; 1995 Jan; 26(1):205-10. PubMed ID: 7713361 [TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. Fernandez F; Misilmeri MA; Felger JC; Devine DP Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912 [TBL] [Abstract][Full Text] [Related]
7. Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box. Bradley BF; Bridges NJ; Starkey NJ; Brown SL; Lea RW Behav Brain Res; 2011 Jan; 216(1):285-92. PubMed ID: 20723567 [TBL] [Abstract][Full Text] [Related]
8. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. Kuribara H; Stavinoha WB; Maruyama Y J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634 [TBL] [Abstract][Full Text] [Related]
9. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the open-field and light/dark tests. Heredia L; Torrente M; Colomina MT; Domingo JL J Pharmacol Toxicol Methods; 2014; 69(2):108-14. PubMed ID: 24374104 [TBL] [Abstract][Full Text] [Related]
10. Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test. Raud S; Innos J; Abramov U; Reimets A; Kõks S; Soosaar A; Matsui T; Vasar E Psychopharmacology (Berl); 2005 Sep; 181(2):347-57. PubMed ID: 15830228 [TBL] [Abstract][Full Text] [Related]
11. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Takeda H; Tsuji M; Matsumiya T Eur J Pharmacol; 1998 May; 350(1):21-9. PubMed ID: 9683010 [TBL] [Abstract][Full Text] [Related]
12. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat. Merlo Pich E; Samanin R Pharmacol Res; 1989; 21(5):595-602. PubMed ID: 2574443 [TBL] [Abstract][Full Text] [Related]
13. Behavioural effects of anxiogenic agents in the common marmoset. Carey GJ; Costall B; Domeney AM; Jones DN; Naylor RJ Pharmacol Biochem Behav; 1992 May; 42(1):143-53. PubMed ID: 1528937 [TBL] [Abstract][Full Text] [Related]
14. The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety. Kalouda T; Pitsikas N Pharmacol Biochem Behav; 2015 Nov; 138():111-6. PubMed ID: 26363313 [TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of paeonol in mice. Mi XJ; Chen SW; Wang WJ; Wang R; Zhang YJ; Li WJ; Li YL Pharmacol Biochem Behav; 2005 Jul; 81(3):683-7. PubMed ID: 15970315 [TBL] [Abstract][Full Text] [Related]
16. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam. Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664 [TBL] [Abstract][Full Text] [Related]
17. A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Imaizumi M; Suzuki T; Machida H; Onodera K Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):83-91. PubMed ID: 7913786 [TBL] [Abstract][Full Text] [Related]
18. Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test. Campos KF; Amaral VC; Rico JL; Miguel TT; Nunes-de-Souza RL Behav Brain Res; 2013 Mar; 240():160-70. PubMed ID: 23195112 [TBL] [Abstract][Full Text] [Related]
19. Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the zero maze test. Heredia L; Torrente M; Colomina MT; Domingo JL J Pharmacol Toxicol Methods; 2013; 68(2):275-283. PubMed ID: 23499652 [TBL] [Abstract][Full Text] [Related]
20. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Kliethermes CL; Finn DA; Crabbe JC Psychopharmacology (Berl); 2003 Sep; 169(2):190-7. PubMed ID: 12783153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]